Optimizing anesthesia strategies to NSCLC patients in VATS procedures: Insights from drug requirements and patient recovery patterns
L Kong, H Yin, D Zhou, X Li, J Zhou - Open Medicine, 2024 - degruyter.com
Understanding the intricate relationship between cancer clinicopathological features and
anesthetics dosage is crucial for optimizing patient outcomes and safety during surgery. This …
anesthetics dosage is crucial for optimizing patient outcomes and safety during surgery. This …
Blood-based Genomic and Cellular Determinants of Response to Neoadjuvant PD-1 Blockade in Patients with Non-Small-Cell Lung Cancer
X Zhang, R Chen, W Li, S Zhang, M Jiang, G Su, Y Liu… - medRxiv, 2021 - medrxiv.org
Background Despite the improved survival observed in PD-1/PD-L1 blockade therapy, there
still is a lack of response to the anti-PD1 therapy for a large proportion of cancer patients …
still is a lack of response to the anti-PD1 therapy for a large proportion of cancer patients …
[PDF][PDF] Transcriptomic Characterization Reveals Blood-based Molecular Signatures of NSCLC Patients in Response to Anti-PD-1 Therapy Combined with …
XT Zhang, RA Chen, WS Li, RH Han, GG Su11… - academia.edu
Background: For patients with non-small cell lung cancer (NSCLC), the PD-1/PD-L1
blockade treatment were incorporated into first-line treatment commonly. Despite the …
blockade treatment were incorporated into first-line treatment commonly. Despite the …